Dexcom DXCM
NASDAQ DXCM
$79.92 -1.15 (-1.42%)
As of: Nov 10, 2026 · 3:41 PM EST

Dexcom (DXCM) EBITDA (2010 - 2026)

Updated

Dexcom (DXCM) posted EBITDA of $401.7 million for Q3 2026, up 31.2% from $306.1 million a year earlier and up 3.9% from the prior quarter.

Analysis

Dexcom (DXCM) EBITDA (2010 - 2026) Analysis & Trends

For the trailing twelve months through Sep 30, 2026, EBITDA at Dexcom was $1.5 billion, up 46.6% year-over-year; for FY2025, it was $1.16 billion, up 42.3% from FY2024.

  • Annual EBITDA has increased for six consecutive years, with a five-year compound annual growth rate of 26.0% (FY2020 to FY2025).
  • In prior years, Dexcom's EBITDA was $817.7 million in FY2024 (+4.3%), $783.7 million in FY2023 (+43.2%), $547.1 million in FY2022 (+48.7%) and $367.8 million in FY2021 (+0.3%).
  • The Q3 2026 figure stands as the highest quarterly EBITDA in data going back to Q3 2010.
  • On a year-over-year basis, EBITDA has increased in each of the last seven quarters, with growth averaging 36.5% over the last eight quarters.
  • The strongest year-over-year quarter for EBITDA in the past five years was Q4 2022, with growth of 394.5%; the weakest was Q4 2021, with a decline of 73.7%.
  • According to Business Quant data, EBITDA for the three prior quarters was $386.5 million (Q2 2026), $322.4 million (Q1 2026) and $388.2 million (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA (Qtr)
1 Thermo Fisher Scientific 265.71 Bn 242.23 Bn 5.13 Bn 3.09 Bn
2 Abbott Laboratories 189.37 Bn 163.23 Bn 7.39 Bn 2.61 Bn
3 Danaher 164.78 Bn 144.43 Bn 3.84 Bn 1.97 Bn
4 Intuitive Surgical 157.85 Bn 138.13 Bn 2.08 Bn 789.70 Mn
5 Medtronic 129.66 Bn 94.91 Bn 6.34 Bn 2.49 Bn
6 Stryker 121.82 Bn 108.01 Bn 4.25 Bn 1.33 Bn
7 Boston Scientific 63.42 Bn 58.86 Bn 3.43 Bn 1.19 Bn
8 Edwards Lifesciences 59.49 Bn 42.69 Bn 1.35 Bn 344.00 Mn
9 Becton Dickinson 58.38 Bn 55.53 Bn 2.32 Bn 1.23 Bn
10 Dexcom 29.96 Bn 21.78 Bn 864.40 Mn 401.70 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 401.70 Mn
Jun 30, 2026 386.50 Mn
Mar 31, 2026 322.40 Mn
Dec 31, 2025 388.20 Mn
Sep 30, 2025 306.10 Mn
Jun 30, 2025 275.60 Mn
Mar 31, 2025 193.70 Mn
Dec 31, 2024 246.70 Mn
Sep 30, 2024 207.30 Mn
Jun 30, 2024 210.10 Mn
Mar 31, 2024 153.60 Mn
Dec 31, 2023 269.40 Mn
Sep 30, 2023 253.70 Mn
Jun 30, 2023 171.80 Mn
Mar 31, 2023 88.80 Mn
Dec 31, 2022 161.70 Mn
Sep 30, 2022 186.70 Mn
Jun 30, 2022 120.60 Mn
Mar 31, 2022 78.10 Mn
Dec 31, 2021 32.70 Mn
API Access

Dexcom EBITDA API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebitda&ticker=DXCM&period=max&api_key=YOUR_API_KEY